Hematogenous dissemination of Candida dubliniensis causing spondylodiscitis and spinal abscess in a HIV-1 and HCV-coinfected patient

Medical Mycology Case Reports

Volumn 8, Issue , 2015, Pages 17-20

  Salzer, Helmut J F ^a   Rolling, Thierry ^a   Klupp, Eva Maria ^a   Schmiedel, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Candida dubliniensis; Hepatitis C virus; Human immunodeficiency virus 1; Spinal abscess; Spondylodiscitis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATAZANVIR; FLUCONAZOLE; LAMIVUDINE; RALTEGRAVIR; SULTAMICILLIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANDIDA DUBLINIENSIS; CANDIDA DUBLINIENSIS INFECTION; CANDIDIASIS; CASE REPORT; CD4 LYMPHOCYTE COUNT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCOMPROMISED PATIENT; INTERVERTEBRAL DISK DEGENERATION; LIVER CIRRHOSIS; LOW BACK PAIN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIXED INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL ABSCESS; SPINE DISEASE; VIRUS LOAD;

EID: 84924027383     PISSN: 22117539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mmcr.2015.02.001     Document Type: Article

References (20)

1. D.J. Sullivan, T.J. Westerneng, K.A. Haynes, D.E. Bennett, and D.C. Coleman Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals Microbiology 141 1995 1507 1521
2. Z. Khan, S. Ahmad, L. Joseph, and R. Chandy Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen PLoS One 7 2012 e32952
3. P.W. Tsang, A.P. Wong, H.P. Yang, and N.F. Li Purpurin triggers caspase-independent apoptosis in Candida dubliniensis biofilms PLoS One 8 2013 e86032
4. A.P. Jackson, J.A. Gamble, T. Yeomans, G.P. Moran, D. Saunders, and D. Harris Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans Genome Res. 19 2009 2231 2244
5. D. Neofytos, S. Huprikar, A. Reboli, M. Schuster, N. Azie, and B. Franks Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry Eur. J. Clin. Microbiol. Infect. Dis. 33 2014 135 141
6. J. Oksi, T. Finnilä, U. Hohenthal, and K. Rantakokko-Jalava Candida dubliniensis spondylodiscitis in an immunocompetent patient. Case report and review of the literature Med. Mycol. Case Rep. 3 2014 4 7
7. C.I. White, and J.E. Haber Intermediates of recombination during mating type switching in Saccharomyces cerevisiae EMBO J. 9 1990 663 673
8. M.C. Arendrup, M. Cuenca-Estrella, C. Lass-Flörl, W. Hope, and the EUCAST-AFST EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST) Clin. Microbiol. Infect. 18 2012 E246 E247
9. B.D. McMillan, G.J. Miller, and J. Nguyen Rare case of exogenous Candida dubliniensis endophthalmitis: a case report and brief review of the literature J. Ophthalmic Inflamm. Infect. 4 2014 11
10. P.K. Patel, J.E. Erlandsen, W.R. Kirkpatrick, D.K. Berg, S.D. Westbrook, and C. Louden. The changing epidemiology of oropharyngeal candidiasis in patients with HIV/AIDS in the era of antiretroviral therapy AIDS Res. Treat. 2012 2012 262471
11. N. Wellinghausen, A. Moericke, S. Bundschuh, W. Friedrich, A.S. Schulz, and S.A. Gatz Multifocal osteomyelitis caused by Candida dubliniensis J. Med. Microbiol. 58 2009 386 390
12. A. Albillos, M. Lario, and M. Alvarez-Mon Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance J. Hepatol. 6 2014 1385 1396
13. V. Arvaniti, G. D'Amico, G. Fede, P. Manousou, E. Tsochatzis, and M. Pleguezuelo Infections in patients with cirrhosis increase mortality 4-fold and should be used in determining prognosis Gastroenterology 1256 2010 1246 1256
14. S.K. Chunchanur, S.D. Nadgir, L.H. Halesh, B.S. Patil, Y. Kausar, and M.R. Chandrasekhar Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients Indian J. Pathol. Microbiol. 52 2009 501 504
15. J.C. Gathe, R.L. Harris, B. Garland, M.W. Bradshaw, and T.W. Williams Candida osteomyelitis: report of five cases and review of literature Am. J. Med. 82 1987 927 937
16. B. Enjalbert, G.P. Moran, C. Vaughan, T. Yeomans, D.M. Maccallum, and J. Quinn Genome-wide gene expression profiling and a forward genetic screen show that differential expression of the sodium ion transporter Ena21 contributes to the differential tolerance of Candida albicans and Candida dubliniensis to osmotic stress Mol. Microbiol. 72 2009 216 228
17. C. Stokes, G.P. Moran, M.J. Spiering, G.T. Cole, D.C. Coleman, and D.J. Sullivan Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans Fungal Genet. Biol. 44 2007 920 931
18. E. Svobodová, P. Staib, J. Losse, F. Hennicke, D. Barz, and M. Jozsi Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils J. Immunol. 189 2012 2502 2511
19. R. Krause, I. Zollner-Schwetz, H.J. Salzer, T. Valentin, J. Rabensteiner, and F. Prüller Elevated levels of interleukin 17A and kynurenine in candidemic patients, compared with levels in noncandidemic patients in the intensive care unit and those in healthy controls J. Infect. Dis. 3 2014 445 451
20. R. Ells, J.L. Kock, and C.H. Pohl Candida albicans or Candida dubliniensis? Mycoses 54 2011 1 16